Agency
Fletcher and O'grady Pediatric Associates
Fletcher and O'grady Pediatric Associates was paid $375K by Medicaid between Sep 2020 and Dec 2024, across 25 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 34% of everything it billed.
33Billing provider infoFLETCHER AND O'GRADY PEDIATRIC ASSOCIATES
AMARILLO, TX 79124
AMARILLO, TX 79124
33aNPI1639197510assigned 07/18/2006
33bProvider typeCase Management Agency
28Total paid$375K
24GClaims15,105
24DCodes billed25
24AFirst – last monthSep 2020 – Dec 2024
Compared with peers
Next to other Case Management Agency providers in Texas
Rank by total paid#143 of 219
Median peer was paid$1.45M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,029 | $18K | |
| 2021 | 3,412 | $86K | |
| 2022 | 4,341 | $116K | |
| 2023 | 3,007 | $82K | |
| 2024incomplete | 3,316 | $74K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34% | 3,675 | 3,166 | $129K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 1,920 | 1,678 | $90K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 12% | 1,643 | 1,481 | $44K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 8.1% | 2,393 | 1,078 | $30K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.5% | 2,029 | 962 | $21K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.8% | 133 | 130 | $10K |
| 87430 | 2.6% | 738 | 659 | $10K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.5% | 243 | 206 | $9K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.6% | 84 | 78 | $6K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.2% | 61 | 57 | $5K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.2% | 116 | 106 | $5K |
| 87634 | 1.0% | 76 | 64 | $4K |
13 more codes
| 99000 | <1% | 357 | $3K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 28 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 206 | $2K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 76 | $2K |
| 90461 | <1% | 335 | $2K | |
| 87807 | <1% | 143 | $1K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 13 | $131.55 |
| 80053 | Comprehensive metabolic panel | <1% | 15 | $106.44 |
| 90686 | <1% | 115 | $0.06 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 32 | $0.00 |
| 90698 | 0% | 42 | $0.00 | |
| 99072 | 0% | 604 | $0.00 | |
| 90670 | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWHITE, KELLY (OFFICE MANAGER)